Medscape

Weekly Cisplatin New Standard in Postop Head and Neck Cancer

For the first time, weekly cisplatin plus radiotherapy (CDDP+RT) has been shown to be not only less toxic than dosing once every three weeks but also achieves better outcomes in patients with ...
ascopubs.org

Phase I/II study of cisplatin (CDDP) and docetaxel (DOC) with concurrent chest radiotherapy followed by full dose of consolidation chemotherapy with CDDP/DOC in locally ...

Intrapatient dose escalation to 800 mg/m2 pemetrexed is safe and feasible in patients with advanced non-small cell lung cancer (NSCLC) who have had prior chemotherapy No significant financial ...
ascopubs.org

Cisplatin (CDDP) plus vinorelbine (VRB) as first-line treatment for patients with advanced non-small cell lung cancer (NSCLC): Molecular correlates

Navelbine (NVB) oral (o) with cisplatin (CDDP) as induction and concomitant to radiotherapy (RT): Final results of an international phase II trial in stage III non-small cell lung cancer (NSCLC) No ...